B3GYE2
Gene name |
APP7_1414 |
Protein name |
UPF0102 protein APP7_1414 |
Names |
|
Species |
Actinobacillus pleuropneumoniae serotype 7 (strain AP76) |
KEGG Pathway |
apa:APP7_1414 |
EC number |
|
Protein Class |
|
Descriptions
The autoinhibited protein was predicted that may have potential autoinhibitory elements via cis-regPred.
Autoinhibitory domains (AIDs)
Target domain |
|
Relief mechanism |
|
Assay |
cis-regPred |
Accessory elements
No accessory elements
Autoinhibited structure
Activated structure
1 structures for B3GYE2
| Entry ID | Method | Resolution | Chain | Position | Source |
|---|---|---|---|---|---|
| AF-B3GYE2-F1 | Predicted | AlphaFoldDB |
No variants for B3GYE2
| Variant ID(s) | Position | Change | Description | Diseaes Association | Provenance |
|---|---|---|---|---|---|
| No variants for B3GYE2 | |||||
No associated diseases with B3GYE2
6 regional properties for B3GYE2
| Type | Name | Position | InterPro Accession |
|---|---|---|---|
| domain | Activin types I and II receptor domain | 26 - 95 | IPR000472 |
| domain | Protein kinase domain | 195 - 487 | IPR000719 |
| domain | Serine-threonine/tyrosine-protein kinase, catalytic domain | 196 - 478 | IPR001245 |
| domain | GS domain | 165 - 195 | IPR003605 |
| active_site | Serine/threonine-protein kinase, active site | 319 - 331 | IPR008271 |
| binding_site | Protein kinase, ATP binding site | 201 - 222 | IPR017441 |
No GO annotations of cellular component
| Name | Definition |
|---|---|
| No GO annotations for cellular component |
1 GO annotations of molecular function
| Name | Definition |
|---|---|
| nucleic acid binding | Binding to a nucleic acid. |
No GO annotations of biological process
| Name | Definition |
|---|---|
| No GO annotations for biological process |
No homologous proteins in AiPD
| UniProt AC | Gene Name | Protein Name | Species | Evidence Code |
|---|---|---|---|---|
| No homologous proteins | ||||
| 10 | 20 | 30 | 40 | 50 | 60 |
| MVQWKTLTKR | SQGANFEQKA | REFLERNGLK | FIAANQQFKC | GELDLIMRQG | DTFVFVEVRQ |
| 70 | 80 | 90 | 100 | 110 | 120 |
| RKSNRFGSAV | ESIDYRKQQK | WLDAANMWLF | TRHKQSLDTA | NCRFDVVAFE | GNDPPLWIPN |
| FLG |